|
|
Volumn 91, Issue 3, 2002, Pages 530-531
|
|
Ultrapure dialysis fluid and response to hepatitis B vaccine [1]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
C REACTIVE PROTEIN;
DIALYSIS FLUID;
ENDOTOXIN;
GEN H B VAX D;
HEMOGLOBIN;
HEPATITIS B SURFACE ANTIBODY;
HEPATITIS B VACCINE;
INTERLEUKIN 6;
PARATHYROID HORMONE;
POLYSULFONE;
SERUM ALBUMIN;
HEMODIALYSIS FLUID;
HEPATITIS B ANTIBODY;
ADULT;
AGED;
ANTIBODY RESPONSE;
ANTIBODY TITER;
ARTIFICIAL KIDNEY;
BODY MASS;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG RESPONSE;
FEMALE;
FISHER EXACT TEST;
HEMOCONCENTRATION;
HEMODIALYSIS;
HEPATITIS B;
HUMAN;
IMMUNE DEFICIENCY;
INFECTION CONTROL;
KIDNEY FAILURE;
LABORATORY TEST;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
NUTRITIONAL STATUS;
PRIORITY JOURNAL;
PURIFICATION;
QUALITY CONTROL;
RANDOMIZED CONTROLLED TRIAL;
SAFETY;
STATISTICAL SIGNIFICANCE;
STUDENT T TEST;
TREATMENT OUTCOME;
ULTRAFILTRATION;
UREMIA;
BLOOD;
CHEMISTRY;
CHRONIC KIDNEY FAILURE;
IMMUNOLOGY;
MIDDLE AGED;
PROSPECTIVE STUDY;
RENAL REPLACEMENT THERAPY;
AGED;
FEMALE;
HEMODIALYSIS SOLUTIONS;
HEPATITIS B ANTIBODIES;
HEPATITIS B VACCINES;
HUMAN;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGE;
PROSPECTIVE STUDIES;
RENAL DIALYSIS;
HUMANS;
MIDDLE AGED;
|
|
EID: 0035996203
PISSN: 00282766
EISSN: None
Source Type: Journal
DOI: 10.1159/000064303 Document Type: Letter |
|
Times cited : (13)
|
|
References (8)
|
